Thank you for the opportunity to help you with your question!
BRAC1, breast cancer , is a gene that has been associated with breast cancer. It is expressed in breast tissue, where it is involved in DNA damage repair. A mutation in BRAC1 increases the chances of breast cancer . BRAC1 is "a tumor suppressor gene," or antioncogene . Patents on the medical diagnostic of the probability of breast cancer of BRAC1 and BRAC2 are owned by Myriad genetics . There is a landmark lawsuit that challenges the validity of gene patents against Myriad genetics .
 BRAC. In Wikipedia. Retrieved on October 2015, from https://en.wikipedia.org/wiki/BRCA1
[2 ] Friedenson B (2007). "The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers". BMC Cancer 7: 152.
 Duncan JA, Reeves JR, Cooke TG (October 1998). "BRCA1 and BRCA2 proteins: roles in health and disease". Molecular pathology : MP 51 (5): 237–47
 US patent 5747282, Skolnick HS, Goldgar DE, Miki Y, Swenson J, Kamb A, Harshman KD, Shattuck-Eidens DM, Tavtigian SV, Wiseman RW, Futreal PA, "7Q-linked breast and ovarian cancer susceptibility gene", issued 1998-05-05, assigned to Myriad Genetics, Inc., The United States of America as represented by the Secretary of Health and Human Services, and University of Utah Research Foundation.
 US patent 5837492, Tavtigian SV, Kamb A, Simard J, Couch F, Rommens JM, Weber BL, "Chromosome 13-linked breast cancer susceptibility gene", issued 1998-11-17, assigned to Myriad Genetics, Inc., Endo Recherche, Inc., HSC Research & Development Limited Partnership, Trustees of the University of Pennsylvania
 Schwartz J (2009-05-12). "Cancer Patients Challenge the Patenting of a Gene". Health. New York Times.
Content will be erased after question is completed.